207 related articles for article (PubMed ID: 11876739)
1. Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease.
Ludgate M; Baker G
Clin Exp Immunol; 2002 Feb; 127(2):193-8. PubMed ID: 11876739
[No Abstract] [Full Text] [Related]
2. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
Baker G; Mazziotti G; von Ruhland C; Ludgate M
Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454
[TBL] [Abstract][Full Text] [Related]
3. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
[TBL] [Abstract][Full Text] [Related]
4. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease.
Costagliola S; Many MC; Denef JF; Pohlenz J; Refetoff S; Vassart G
J Clin Invest; 2000 Mar; 105(6):803-11. PubMed ID: 10727449
[TBL] [Abstract][Full Text] [Related]
5. Animal model of thyroid-associated orbitopathy.
Ludgate M
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S158-9. PubMed ID: 10614911
[TBL] [Abstract][Full Text] [Related]
6. Development of an animal model of autoimmune thyroid eye disease.
Many MC; Costagliola S; Detrait M; Denef F; Vassart G; Ludgate MC
J Immunol; 1999 Apr; 162(8):4966-74. PubMed ID: 10202044
[TBL] [Abstract][Full Text] [Related]
7. Unique properties of orbital connective tissue underlie its involvement in Graves' disease.
Smith TJ
Minerva Endocrinol; 2003 Sep; 28(3):213-22. PubMed ID: 14605603
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice.
Kita-Furuyama M; Nagayama Y; Pichurin P; McLachlan SM; Rapoport B; Eguchi K
Clin Exp Immunol; 2003 Feb; 131(2):234-40. PubMed ID: 12562382
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune endocrine diseases.
De Baets MH
Year Immunol; 1989; 4():264-75. PubMed ID: 2564710
[No Abstract] [Full Text] [Related]
10. A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity.
Kendall-Taylor P; Atkinson S; Holcombe M
Br Med J (Clin Res Ed); 1984 Apr; 288(6425):1183-6. PubMed ID: 6424781
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Graves' ophthalmopathy.
Spitzweg C; Heufelder AE
Int Arch Allergy Immunol; 1997 Sep; 114(1):101-2. PubMed ID: 9303340
[No Abstract] [Full Text] [Related]
12. [Pathogenesis of immunogenic hyperthyroidism and endocrine orbitopathy].
Heufelder AE; Spitzweg C
Internist (Berl); 1998 Jun; 39(6):599-606. PubMed ID: 9677517
[No Abstract] [Full Text] [Related]
13. The thyrotropin receptor in thyroid eye disease.
Ludgate M; Crisp M; Lane C; Costagliola S; Vassart G; Weetman A; Daunerie C; Many MC
Thyroid; 1998 May; 8(5):411-3. PubMed ID: 9623732
[TBL] [Abstract][Full Text] [Related]
14. Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease.
Kita M; Ahmad L; Marians RC; Vlase H; Unger P; Graves PN; Davies TF
Endocrinology; 1999 Mar; 140(3):1392-8. PubMed ID: 10067867
[TBL] [Abstract][Full Text] [Related]
15. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy.
Boschi A; Daumerie Ch; Spiritus M; Beguin C; Senou M; Yuksel D; Duplicy M; Costagliola S; Ludgate M; Many MC
Br J Ophthalmol; 2005 Jun; 89(6):724-9. PubMed ID: 15923509
[TBL] [Abstract][Full Text] [Related]
16. Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice.
Nakahara M; Johnson K; Eckstein A; Taguchi R; Yamada M; Abiru N; Nagayama Y
Endocrinology; 2012 Apr; 153(4):2034-42. PubMed ID: 22334716
[TBL] [Abstract][Full Text] [Related]
17. Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination.
Rao PV; Watson PF; Weetman AP; Carayanniotis G; Banga JP
Endocrinology; 2003 Jan; 144(1):260-6. PubMed ID: 12488353
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.
Moshkelgosha S; So PW; Deasy N; Diaz-Cano S; Banga JP
Endocrinology; 2013 Sep; 154(9):3008-15. PubMed ID: 23900776
[TBL] [Abstract][Full Text] [Related]
19. Immunization of mice with a newly identified thyroid-stimulating hormone receptor splice variant induces Graves'-like disease.
Endo T; Kobayashi T
J Autoimmun; 2013 Jun; 43():18-25. PubMed ID: 23538203
[TBL] [Abstract][Full Text] [Related]
20. Current insights into animal models of Graves' disease and orbitopathy.
Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
